Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


elbion GMBH

Division of Acorda Therapeutics Inc.

Latest From Visum Therapeutics Inc.

Out Of The Blocks, December 2012

Brief profiles of these recently formed companies: Invenra, Cibiem, PharmAria, Scholar Rock, Sengenix, and Visum Therapeutics.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • 4 AZA Bioscience NV
  • elbion AG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Acorda Therapeutics Inc.
  • Senior Management
  • Bernd Kastler, CEO
    Thomas Taapken, CFO
    Thomas Kronbach, CSO
  • Contact Info
  • elbion GMBH
    Phone: (49) 351 404 33 308
    Meißner Str. 191
    Radebeul, 01445